• Je něco špatně v tomto záznamu ?

Measurement uncertainty evaluation from correlated validation data: Determination of elemental impurities in pharmaceutical products by ICP-MS

D. Milde, T. Pluháček, M. Kuba, J. Součková, RJN. Bettencourt da Silva

. 2020 ; 220 (-) : 121386. [pub] 20200710

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019773

Pharmaceutical products as well as active pharmaceutical ingredients (APIs) are checked for levels of elemental contaminants to guarantee medicines administration will not involve the consumption of level of contaminants greater than their maximum admissible intake. However, the conformity decision is affected by the measurement uncertainty function of analytical steps performance, used standards quality and how measurement performance is assessed during method validation. When an ingredient is considered conform, since the measured concentration is lower than the maximum limit, the risk of a false acceptance depends on how close the measured concentration is from the limit and on the measurement uncertainty. The analytical methods used for pharmaceutical analysis should be validated by ICH and USP recommendations, in order to prove measurements are fit for purpose. The validation must also be economically feasible and have an acceptable duration. This work discusses how to evaluate the uncertainty of elemental analysis in pharmaceutical ingredients from data collected during the validation of the analytical method by following ICH guidelines and USP chapters. A top-down uncertainty evaluation based on results from the analysis of a model API intermediate, with the native analyte after spiking at three concentration levels, where analyses are performed by two analysts in two different days, is presented. The impact of the correlation of some uncertainty components of collected results on the uncertainty evaluation is discussed and considered in the calculations. The developed measurement model was checked by a cross-validation procedure where some validation data was randomly removed and used for an independent model control. The developed uncertainty evaluation methodology was successfully applied to the analysis of Pd in a model API intermediate by ICP-MS after a micro-wave assisted acid digestion, where the risk of a false acceptance of the pharmaceuticals is determined. The measurement performance data and used spreadsheet are made available as Supplementary Material.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019773
003      
CZ-PrNML
005      
20220328110314.0
007      
ta
008      
210728s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.talanta.2020.121386 $2 doi
035    __
$a (PubMed)32928409
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Milde, David, $u Department of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic $d 1973- $7 ola2002157911
245    10
$a Measurement uncertainty evaluation from correlated validation data: Determination of elemental impurities in pharmaceutical products by ICP-MS / $c D. Milde, T. Pluháček, M. Kuba, J. Součková, RJN. Bettencourt da Silva
520    9_
$a Pharmaceutical products as well as active pharmaceutical ingredients (APIs) are checked for levels of elemental contaminants to guarantee medicines administration will not involve the consumption of level of contaminants greater than their maximum admissible intake. However, the conformity decision is affected by the measurement uncertainty function of analytical steps performance, used standards quality and how measurement performance is assessed during method validation. When an ingredient is considered conform, since the measured concentration is lower than the maximum limit, the risk of a false acceptance depends on how close the measured concentration is from the limit and on the measurement uncertainty. The analytical methods used for pharmaceutical analysis should be validated by ICH and USP recommendations, in order to prove measurements are fit for purpose. The validation must also be economically feasible and have an acceptable duration. This work discusses how to evaluate the uncertainty of elemental analysis in pharmaceutical ingredients from data collected during the validation of the analytical method by following ICH guidelines and USP chapters. A top-down uncertainty evaluation based on results from the analysis of a model API intermediate, with the native analyte after spiking at three concentration levels, where analyses are performed by two analysts in two different days, is presented. The impact of the correlation of some uncertainty components of collected results on the uncertainty evaluation is discussed and considered in the calculations. The developed measurement model was checked by a cross-validation procedure where some validation data was randomly removed and used for an independent model control. The developed uncertainty evaluation methodology was successfully applied to the analysis of Pd in a model API intermediate by ICP-MS after a micro-wave assisted acid digestion, where the risk of a false acceptance of the pharmaceuticals is determined. The measurement performance data and used spreadsheet are made available as Supplementary Material.
650    _2
$a kontaminace léku $7 D004340
650    12
$a léčivé přípravky $7 D004364
650    _2
$a referenční standardy $7 D012015
650    _2
$a spektrální analýza $7 D013057
650    _2
$a nejistota $7 D035501
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pluháček, Tomáš $u Department of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic
700    1_
$a Kuba, Martin $u Department of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic; Department of Contaminants, State Veterinary Institute in Olomouc, Hulínská 2286, 767 60, Kroměříž, Czech Republic
700    1_
$a Součková, Jitka $u Department of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic
700    1_
$a Bettencourt da Silva, Ricardo J N $u Centro de Química Estrutural, Faculdade de Ciências da Universidade de Lisboa, Edifício C8, Campo Grande, 1749-016, Lisboa, Portugal. Electronic address: rjsilva@fc.ul.pt
773    0_
$w MED00004484 $t Talanta $x 1873-3573 $g Roč. 220, č. - (2020), s. 121386
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32928409 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20220328110312 $b ABA008
999    __
$a ok $b bmc $g 1690559 $s 1140219
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 220 $c - $d 121386 $e 20200710 $i 1873-3573 $m Talanta $n Talanta $x MED00004484
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...